Cholelithiasis and choledocholithiasis are major health problems in the United States, presently affecting an estimated 20 million adults (1), with total costs of $6.2 billion in 2004 (2). Adult gallstone disease is associated with increased all-cause mortality, as well as increased cardiovascular and cancer mortality (3). Several risk factors for gallstones in adults are well established, including age, female sex, Hispanic ethnicity, obesity, use of female sex hormones, pregnancy, sedentary lifestyle, and a family history of gallstones (1); however, scant information is available regarding risk factors for gallstones in the pediatric population.
Although gallstones are a relatively common outcome in obese adults, gallstones in children and adolescents are rare and linked to conditions such as chronic hemolysis (4). Some clinical reports suggest that hemolytic diseases are no longer the most frequent cause of pediatric gallbladder disease (5,6). Concomitant with the epidemic of childhood obesity (7,8) and the shift toward extreme childhood obesity (7), the prevalence of gallstones in children and adolescents may be increasing due to childhood obesity. Results from small hospital-based studies suggest that obesity may be a risk factor for gallstones in adolescents (9,10). Cholecystectomy is also becoming more frequent in this age group (11). Given the observations that the prevalence of dyslipidemia and diabetes is also increasing in pediatric populations (12,13), pediatricians may have to be increasingly prepared to recognize and treat conditions in children that traditionally only occurred in adults.
No information is available on the magnitude of the association among overweight, moderate, and extreme obesity, and the risk of gallstones in children and adolescents. It is largely unknown whether gallstone risk factors established for adults also apply to pediatric populations. Given the decreasing age of puberty onset in girls (14,15) and the link among obesity, female sex hormone exposure, and gallstone risk in adults (16), we speculated that girls may be at particularly high risk for gallstones, especially if they are obese and/or take oral contraceptives.
To estimate the magnitude of the association between body mass index (BMI) and the occurrence of gallstones in children, we investigated this association in children with varying degrees of obesity using a multiethnic population–based cohort of children and adolescents in southern California (7).
Study Design and Subjects
For this cross-sectional study, we used a subset of patients enrolled in a large population-based cohort study, the Kaiser Permanente Southern California (KPSC) Children's Health Study 2007–2009 (n = 920,034) (17). Patients enrolled in the study were members of a prepaid integrated health plan between January 1, 2007 and December 31, 2009. KPSC is the largest health care provider in southern California and provides health care service to >3.4 million members, about 16% of the total population in the service area. Members received their care in medical offices and hospitals owned by KPSC. Comprehensive electronic health records have been used since enrollment in the KPSC Children's Health Study. We excluded patients who were pregnant (n = 6856), younger than 10 years (n = 401,232), and had a preexisting diagnosis of cholelithiasis >24 months before the study enrollment (n = 386), cystic fibrosis (n = 318), or hemolytic anemia (n = 426), leaving 510,816 patients for the analyses. The study protocol was reviewed and approved by the institutional review board of KPSC.
Patients with gallstones in the gallbladder and ducts of the biliary tract (cholelithiasis and choledocholithiasis) were identified by extracting International Classification of Disease, 9th Modification (ICD-9) code 574 in electronic health records documenting inpatient and outpatient medical encounters. We identified patients whose gallstone disease was diagnosed within 24 months before study enrollment. According to the study protocol and a priori defined selection criteria, subjects with gallstones >24 months before the study baseline were excluded from the analysis to limit this cross-sectional study to cases with a diagnosis <2 years before their first available BMI in the electronic medical record; however, a sensitivity analysis performed a posteriori showed virtually identical results.
To rule out that gallstone suspicion was diagnosed as gallstone disease, we performed a validation study in a random subsample of 394 patients with an ICD-9 code 574 indicating gallstone disease. The diagnosis was confirmed or rejected by manual chart review of the electronic medical record using physician notes, radiology reports, and surgical pathology reports from cholelithiasis or choledocholithiasis. The positive predictive value (PPV) of the diagnosis by ICD-9 code was 90.9% and did not differ by weight class.
Body Weight and Height
Body weight and height were extracted from electronic health records, and BMI was calculated as weight (kilograms) divided by the square of the height (meters). For patients enrolled into the study in years 2007, 2008, and 2009, the median BMI-for-age of all of the encounters in the year of study enrollment for a patient was used for analysis. Based on a validation study including 15,000 patients with 45,980 medical encounters, the estimated error rate in body weight and height data was <0.4% (18).
Definitions of overweight and obesity in children and adolescents are based on the sex-specific BMI-for-age growth charts developed by the Centers for Disease Control and Prevention and the World Health Organization definitions for overweight and obesity in adults (19–21). Children were categorized as underweight (BMI-for-age <5th percentile), normal weight (BMI-for-age ≥5th to <85th percentile), overweight (BMI-for-age ≥85th to <95th percentile or a BMI ≥25 to <30 kg/m2), moderately obese (BMI-for-age ≥95th to <1.2 × 95th percentile or a BMI ≥30–<35 kg/m2), and extremely obese (BMI-for-age ≥1.2 × 95th percentile or a BMI ≥35 kg/m2).
Race/Ethnicity and Socioeconomic Status
We obtained race and ethnicity information from health plan administrative records and birth records. We categorized race/ethnicity as non-Hispanic white, Hispanic, black, Asian or Pacific Islander, and other, multiple, or unknown race/ethnicity. A validation study compared health plan administrative records and birth certificate records of 325,810 children (22). The PPV for Hispanic ethnicity was 95.6%. PPVs for non-Hispanic white, Hispanic black, Asian/Pacific Islander, and other race were 89.3%, 86.6%, 73.8%, 51.8%, and 1.2%, respectively (22).
When race and ethnicity information was unknown (31.7%), administrative records were supplemented by an imputation algorithm based on surname lists and address information derived from the US Census Bureau (23–25). Hispanic ethnicity and Asian race were assigned based on surnames. For blacks and non-Hispanic whites, the child's home address was used to link racial/ethnic information from the US Census Bureau. Race/ethnicity was hierarchically assigned using probability cutoffs of >50% for Asian surname, >50% for Hispanic surname, >75% for black race from geocoding, and white race >45% from geocoding if no other assignment could be made before. The specificity and PPVs were >98% for all of the races/ethnicities (7).
As measures of socioeconomic status, neighborhood education was estimated based on the linkage of health plan members’ addresses via geocoding with US Census block data.
Oral Contraceptive Use
Information on oral contraceptive use was extracted from pharmacy records and was defined as any dispensed prescription of oral contraceptives within 24 months before the study enrollment.
Differences in the distribution of basic demographics across groups defined by weight class were assessed with the χ2 test. For each patient, age was assigned based on their age on July 1 of the year of study enrollment.
Logistic regression models were generated to estimate odds ratios (ORs) and their 95% confidence intervals (CI) for gallstones versus potential risk factors such as sex (male vs female), race/ethnicity (non-Hispanic white, Hispanic, black, Asian or Pacific Islander, and other/multiple/unknown race), age group (younger children 10–14 years of age vs older children 15–19 years of age), weight class (under-/normal-weight [reference], overweight, moderate obesity, and extreme obesity), and the likelihood of neighborhood education below high school. The categories underweight and normal weight were collapsed due to the small number of cases in the group of underweight children (n = 11,456, of which 9 patients had gallstones); the ORs for gallstones of underweight and normal-weight patients were comparable. The ORs for potential gallstone risk factors are presented as crude ORs and mutually adjusted for all of the other risk factors listed: sex, race/ethnicity, age group, weight class, and low education level. To examine whether the association between body weight class and gallstones was modified by sex and oral contraceptive use, we conducted both stratified analyses and formal tests of interaction; the statistical significance of the latter was evaluated using likelihood-ratio χ2. All of the analyses were conducted using SAS 9.0 (SAS Institute, Cary, NC).
The prevalence of overweight, obesity, and extreme obesity was 19.6%, 13.7%, and 7.7%, respectively. Adolescent patients who were overweight, moderately, or extremely obese were more likely to be older (P < 0.001), boys (P < 0.001), and Hispanic or black, than those who were under-/normal-weight (P < 0.001) (Table 1).
We identified 766 patients with gallstones in the gallbladder or biliary ducts. The adjusted OR for gallstones was higher in girls (OR 4.42, 95% CI 3.69%–5.29%), older children (OR 5.50, 95% CI 4.52%–6.69%), Hispanics (OR 1.55, 95% CI 1.26%–1.91%), and individuals living in areas with low neighborhood education (OR 1.23, 95% CI 1.06%–1.44%, Table 2).
The prevalence of gallstones increased with increasing weight class, but the association was stronger in girls than in boys (P for sex × weight class interaction <0.001). The adjusted ORs for gallstones were 1.00, 1.46, 1.83, and 3.10 (95% CI 1.99%–4.83%) in under-/normal-weight (reference), overweight, moderately obese, and extremely obese boys, respectively (Fig. 1). In contrast, the ORs of gallstones were 1.00, 2.73, 5.75, and 7.71 (95% CI 6.13%–9.71%) in under-/normal-weight (reference), overweight, moderately obese, and extremely obese girls, respectively. We did not observe interactions between weight class and race/ethnicity (P > 0.150).
Oral contraceptive use was associated with higher odds for gallstones (OR 2.00, 95% CI 1.66%–2.40%). The association between oral contraceptive use and gallstones was modified by weight class (P for interaction weight class × oral contraceptive use = 0.023). Using girls of under-/normal-weight who did not use oral contraceptives as the reference group, girls who used oral contraceptives were at higher odds for gallstones than their counterparts in the same weight class (Fig. 2); however, the odds for gallstones among extremely obese girls were comparable, regardless of oral contraceptive use.
This analysis of a large multiethnic cohort of children and adolescents in southern California showed 4 key findings. First, excessive body weight was associated with gallstones in youth. Second, Hispanic youth had the highest odds of developing gallstones compared with youth of other races/ethnicities. Third, the association between excessive body weight and gallstones was stronger in girls than in boys. Fourth, oral contraceptive use contributed to gallstone disease in girls.
Obesity is a strong, well-established risk factor for gallstone disease in adults (26–28). The key factors for cholesterol gallstone formation are the supersaturation of bile with cholesterol and gallbladder dysmotility (28). Cholesterol supersaturation can be caused by an increased hepatic cholesterol uptake or an increased de novo cholesterol synthesis. Obese individuals show increased hydroxy-3-methylglutaryl-coenzyme A reductase activity and, consequently, increased hepatic secretion of biliary cholesterol (29). With an earlier onset of obesity (7,8), it can be expected that lithogenic bile will occur earlier in a patient's life, especially with the onset of extreme obesity during childhood. In obese children referred for weight loss, a systematic screening for gallstones revealed that patients with gallstone disease were more severely obese than those without gallstones (9); however, because this hospital-based study (9) lacked a normal-weight control group, it cannot provide estimates of the magnitude of association between obesity and gallstone disease. Using a population-based approach in a small sample of children (n = 307) (10), the same group of researchers concluded that obesity may be a risk factor for gallstone disease; however, this conclusion was based on only 3 cases of gallstone disease in the cohort. Thus, although other studies examined a limited number of cases and lacked the power to investigate the effects of being overweight and gallstone risk, results from our large, population-based study found that being overweight during childhood or adolescence is associated with a >2-fold higher odds of gallstone disease, whereas moderate and extreme obesity are associated with a 4- and 6-fold higher odds of gallstone disease, respectively.
It is well established that women are at higher risk for gallstones than men (1). In an obese pediatric population referred for weight loss, female sex has also been suggested to be a risk factor for pediatric gallstone disease (9). Compared with studies in women (30), results from our study suggest that adolescent girls already have a >4 times higher odds for gallstone disease than their male counterparts.
Another retrospective study in 31 adolescent girls 14 to 20 years old found a higher prevalence of obesity in girls with gallstones than in the general population (31). In our study, the strength of the association between obesity and gallstone disease was also much stronger in girls than in boys. Although extremely obese boys have a 3-fold higher odds of gallstone disease, extremely obese girls have almost an 8-fold odds of gallstone disease. Surprisingly, these ORs are comparable with estimates from prospective studies in women in which women with a BMI >32 kg/m2 showed an age-adjusted relative risk of 6.0 (95% CI 4.0%–9.0%) (32).
Although body weight is an established risk factor in men, the association between body weight and gallstone disease appears to be weaker and less consistent in men than in women (33–36). Although body weight alone may not entirely account for the risk of gallstones in men, a stronger association was observed between abdominal obesity and gallstone disease (26).
In addition to obesity, exogenous estrogen exposure increases the risk of gallstones in women (28,37). Results from animal and human studies suggest that estrogen increases the hepatic secretion of biliary cholesterol, which increases the cholesterol saturation of the bile (37). Although exogenous estrogen exposure from oral contraceptives in girls was of relatively short duration compared with women, we found that oral contraceptive use was associated with a 2-fold higher odds for gallstones after adjustments for race/ethnicity, obesity, and other factors; however, because of the cross-sectional nature of the data and lack of information on duration of estrogen exposure from oral contraceptives in our sample, these results should be interpreted with care.
Studies on oral contraceptive use as a modifier of the association between obesity and gallstones are scant. In women, the association between obesity and cholecystectomy was similar between nonusers and users of hormone replacement therapy (27). Results from our study, however, suggest that the association between body weight and gallstones was stronger in girls using oral contraceptives than in those who did not use oral contraceptives. Compared with normal weight girls who had never used oral contraceptives, moderately obese girls using oral contraceptives showed a 15-fold odds of gallstones compared with about 6-fold odds for moderately obese girls who had not used oral contraceptives.
Racial and ethnic disparities in gallstone disease have been reported in adults (2,38,39); however, such data are lacking in children. Among women, the risk of gallbladder disease is highest among American Indians, followed by Hispanics, non-Hispanic whites, and non-Hispanic blacks. Among men, the prevalence of gallstones was similar between Hispanic and non-Hispanic individuals (38). In our study, Hispanic youth had 55% higher odds for gallstone disease than their non-Hispanic white counterparts after adjusting for sex, body weight, age, and low neighborhood education level. This suggests that racial and ethnic disparities as described in adults also exist in children. Further longitudinal data are needed to investigate factors contributing to the observed racial and ethnic disparities and to implement strategies to reduce and eliminate such disparities.
Race and ethnicity are subject to potential misclassification due to imputation of missing race/ethnicity information in approximately one-third of the study population; however, results did not differ when only children with known race/ethnicity information from administrative records were analyzed. Moreover, prevalence of obesity in children with missing race/ethnicity information was comparable with the overprevalence of obesity, suggesting that the racial/ethnic distribution of children with missing race/ethnicity was comparable with those whose race/ethnicity was known (7).
Our study benefited from an extremely large multiethnic and diverse pediatric population base covering almost 16% of the service area in southern California; however, because of the cross-sectional design of the present study, which does not allow causal conclusions, our findings should be interpreted with care. Both exposure and outcome have been simultaneously assessed, and therefore no conclusions pertaining to causality can be made; however, several mechanisms have been suggested to explain the association between obesity and gallstone disease, and obesity is an established risk factor for gallstones in adults. It is unlikely that gallstones in turn could have caused obesity or contributed to higher body weight.
The present study is based on a diagnosis of gallstone disease from electronic health records. We cannot rule out a potential underdiagnosis of asymptomatic gallstone disease in patients who have not been examined. The prevalence of asymptomatic gallstone disease is poorly documented in pediatric populations. One study estimated that approximately 20% of pediatric patients with gallstones are asymptomatic (6), which is markedly lower than in adults in whom 80% of patients are asymptomatic (1). Because of the nature of the disease and the symptoms, nondifferential misclassification due to underdiagnosis can be assumed across weight classes, which would most likely bias our results toward the null.
To address overdiagnosis of gallstone disease because a suspicion of gallstones may have been falsely coded as gallstone disease, we performed a manual chart review of almost 400 youth. The amount of unverified diagnoses of gallstone disease in youths was <10%.
Our study cannot distinguish between cholesterol and pigment gallstones. To reduce the number of individuals with pigment gallstones, patients with hemolytic anemia were excluded from the present study. Pigment gallstones are associated with older age, but the underlying cause in adults is often unknown (40); data on causes of pigment gallstones besides hemolytic anemia in youth are sparse. Because the exclusion was based on a diagnosis of hemolytic anemia, we cannot rule out that some pigment gallstones caused by other or unknown causes were missed.
Exposure to oral contraceptives has been extracted from electronic medical records and does not contain drugs dispensed by other organizations such as the California Family Planning Program. Therefore, we cannot exclude an underestimation of girls who were using oral contraceptives and misclassified as unexposed; however, this misclassification would most likely bias our results toward the null.
The obesity epidemic in children may now put more children at risk of developing gallstone disease. Due to the shift toward extreme childhood obesity, especially in minority children, pediatricians can expect to face an increasing number of children affected by gallstone disease, which has previously been limited to adults. Risk factors identified in adults such as female sex, Hispanic ethnicity, obesity, and oral contraceptive use may also apply to children, which can assist pediatricians in identifying pediatric populations at risk. Although pediatricians may have to be made aware of the risk for gallstone disease in pediatric populations, information on the prevalence of asymptomatic gallstones is needed to fully understand the risk of extreme pediatric obesity.
We thank Theresa Im and Monica L. Levitt for their excellent technical support.
1. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am 2010; 39:157–169.
2. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009; 136:376–386.
3. Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011; 140:508–516.
4. Palasciano G, Serio G, Portincasa P, et al. Gallbladder volume in adults, and relationship to age, sex, body mass index, and gallstones: a sonographic population study. Am J Gastroenterol 1992; 87:493–497.
5. Miltenburg DM, Schaffer R 3rd, Breslin T, et al. Changing indications for pediatric cholecystectomy. Pediatrics 2000; 105:1250–1253.
6. Holcomb GW Jr, Holcomb GW 3rd. Cholelithiasis in infants, children, and adolescents. Pediatr Rev 1990; 11:268–274.
7. Koebnick C, Smith N, Coleman KJ, et al. Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr 2010; 157:26–31.
8. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA 2010; 303:242–249.
9. Kaechele V, Wabitsch M, Thiere D, et al. Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development. J Pediatr Gastroenterol Nutr 2006; 42:66–70.
10. Kratzer W, Walcher T, Arnold F, et al. Gallstone prevalence and risk factors for gallstone disease in an urban population of children and adolescents. Z Gastroenterol 2010; 48:683–687.
11. Waldhausen JH, Benjamin DR. Cholecystectomy is becoming an increasingly common operation in children. Am J Surg 1999; 177:364–367.
12. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362–2374.
13. Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med 2002; 346:854–855.
14. Ahmed ML, Ong KK, Dunger DB. Childhood obesity and the timing of puberty. Trends Endocrinol Metab 2009; 20:237–242.
15. Sandhu J, Ben-Shlomo Y, Cole TJ, et al. The impact of childhood body mass index on timing of puberty, adult stature and obesity: a follow-up study based on adolescent anthropometry recorded at Christ's Hospital (1936–1964). Int J Obes 2006; 30:14–22.
16. Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 1993; 83:1113–1120.
17. Koebnick C, Coleman KJ, Black MH, et al. Cohort Profile: the KPSC Children's Health Study, a population-based study of 920 000 children and adolescents in southern California. Int J Epidemiol 2011 (Epub ahead of print).
18. Smith N, Coleman KJ, Lawrence JM, et al. Body weight and height data in electronic medical records of children. Int J Pediatr Obes 2010; 5:237–242.
19. World Health Organization. Technical Report Series 894. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization; 2000.
20. Flegal KM, Wei R, Ogden CL, et al. Characterizing extreme values of body mass index for age by using the 2000 Centers for Disease Control and Prevention growth charts. Am J Clin Nutr 2009; 90:1314–1320.
21. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 2002; 11:1–190.
22. Smith N, Iyer RL, Langer-Gould AM, et al. Health plan administrative records versus birth certificate records: quality of race and ethnicity information in children. BMC Health Serv Res 2010; 10:316.
24. Fiscella K, Fremont AM. Use of geocoding and surname analysis to estimate race and ethnicity. Health Serv Res 2006; 41:1482–1500.
25. Word DL, Perkins RC. Building a Spanish Surname List for the 1990's: A New Approach to an Old Problem. Technical working paper no.13. Washington, DC: US Bureau of the Census;1996.
26. Tsai CJ, Leitzmann MF, Willett WC, et al. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004; 80:38–44.
27. Tsai CJ, Leitzmann MF, Willett WC, et al. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 2006; 55:708–714.
28. Yoo EH, Lee SY. The prevalence and risk factors for gallstone disease. Clin Chem Lab Med 2009; 47:795–807.
29. Stahlberg D, Rudling M, Angelin B, et al. Hepatic cholesterol metabolism in human obesity. Hepatology 1997; 25:1447–1450.
30. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006; 20:981–996.
31. Honore LH. Cholesterol cholelithiasis in adolescent females: its connection with obestiy, parity, and oral contraceptive use—a retrospective study of 31 cases. Arch Surg 1980; 115:62–64.
32. Maclure KM, Hayes KC, Colditz GA, et al. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321:563–569.
33. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997; 26:809–818.
34. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology 1987; 7:913–917.
35. Kono S, Kochi S, Ohyama S, et al. Gallstones, serum lipids, and glucose tolerance among male officials of self-defense forces in Japan. Dig Dis Sci 1988; 33:839–844.
36. Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gall stone disease: a case-control study. Br Med J 1984; 288:1113–1119.
37. Wang HH, Liu M, Clegg DJ, et al. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta 2009; 1791:1037–1047.
38. Everhart JE. Gallstones and ethnicity in the Americas. J Assoc Acad Minor Phys 2001; 12:137–143.
39. Nguyen GC, Tuskey A, Jagannath SB. Racial disparities in cholecystectomy rates during hospitalizations for acute gallstone pancreatitis: a national survey. Am J Gastroenterol 2008; 103:2301–2307.
40. Trotman BW. Pigment gallstone disease. Gastroenterol Clin North Am 1991; 20:111–126.